Cite
Breast cancer risk inBRCA1/2mutation carriers and noncarriers under prospective intensified surveillance
MLA
Engel, Christoph, et al. Breast Cancer Risk InBRCA1/2mutation Carriers and Noncarriers under Prospective Intensified Surveillance. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238107556&authtype=sso&custid=ns315887.
APA
Engel, C., Fischer, C., Zachariae, S., Bucksch, K., Rhiem, K., Giesecke, J., Herold, N., Wappenschmidt, B., Huebbel, V., Maringa, M., Reichstein-Gnielinski, S., Hahnen, E., Bartram, C. R., Dikow, N., Schott, S., Speiser, D., Horn, D., Fallenberg, E. M., Kiechle, M., … Schmutzler, R. K. (2020). Breast cancer risk inBRCA1/2mutation carriers and noncarriers under prospective intensified surveillance.
Chicago
Engel, Christoph, Christine Fischer, Silke Zachariae, Karolin Bucksch, Kerstin Rhiem, Jutta Giesecke, Natalie Herold, et al. 2020. “Breast Cancer Risk InBRCA1/2mutation Carriers and Noncarriers under Prospective Intensified Surveillance.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1238107556&authtype=sso&custid=ns315887.